| Title |
Casopitant: a novel NK1-receptor antagonist in the prevention of chemotherapy-induced nausea and vomiting
|
|---|---|
| Published in |
Therapeutics and Clinical Risk Management, May 2009
|
| DOI | 10.2147/tcrm.s4026 |
| Pubmed ID | |
| Authors |
Christina Ruhlmann, Jørn Herrstedt |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 January 2023.
All research outputs
#8,534,976
of 25,373,627 outputs
Outputs from Therapeutics and Clinical Risk Management
#461
of 1,323 outputs
Outputs of similar age
#36,976
of 104,032 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#4
of 6 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,323 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has gotten more attention than average, scoring higher than 55% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 104,032 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 18th percentile – i.e., 18% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 6 others from the same source and published within six weeks on either side of this one. This one has scored higher than 2 of them.